Results 341 to 350 of about 3,163,010 (367)
Some of the next articles are maybe not open access.

Treatment of Acute Leukemia

Annals of Internal Medicine, 1968
Excerpt I would rather learn from one bird how to sing than teach ten thousand stars how not to dance. e. e.
openaire   +3 more sources

Acute Ocular Leukemia

American Journal of Ophthalmology, 1979
A 71-year-old woman had a history of recent weight loss and bilateral decreased visual acuity, bilateral serous detachment, and mental depression. Fluorescein angiograms showed a myriad of retinal pigment epithelial leakage points. Despite extensive evaluation, the cause of her weight loss and ocular process remained uncertain until her death, when ...
Marilyn C. Kincaid   +2 more
openaire   +3 more sources

Acute Leukemia in Children

AJN, American Journal of Nursing, 1975
One of the most encouraging endeavors in pediatric oncology in recent years has been the development of treatment regimens for acute lymphoblastic leukemia. Remission in children with leukemia was first induced with aminopterin in 1948(1). Since then, other drugs have been used in numerous combinations.
openaire   +3 more sources

Acute basophilic leukemia

European Journal of Haematology, 2001
Abstract: Acute basophilic leukemia has recently been included into a revised classification of acute leukemias proposed by the WHO panel. Due to the rarity of the disease, consistent diagnostic criteria are lacking. We report on two cases of acute basophilic leukemia that occurred in our department during the last 10 yr.
Manuel Aivado   +5 more
openaire   +3 more sources

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Annals of Internal Medicine, 1985
Excerpt The first proposals for the morphologic classification of the acute leukemias by the French-American-British (FAB) group (1) were put forward in the hope that they might serve as a basis fo...
J. Bennett   +6 more
semanticscholar   +1 more source

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.

Journal of Clinical Oncology, 2003
An International Working Group met to revise the diagnostic and response criteria for acute myelogenous leukemia originally published in 1990, as well as to provide definitions of outcomes and reporting standards to improve interpretability of data and ...
B. Cheson   +19 more
semanticscholar   +1 more source

Acute Myelocytic Leukemia

Archives of Internal Medicine, 1976
The difference between the chemotherapeutic response in patients with acute myelocytic leukemia (AML) and in those with acute lymphocytic leukemia (ALL) would appear to be more a problem of lack of regeneration of normal myeloid tissues than a lack of susceptibility of the neoplastic cell to chemotherapy.
Wallace Hj   +10 more
openaire   +3 more sources

Acute Promyelocytic Leukemia

Journal of Pediatric Hematology/Oncology, 1995
Significant advances have occurred in the diagnosis, treatment, and long-term outcome of patients with acute promyelocytic leukemia (APL). The purpose of this review is to describe the molecular genetics of this disease, the use of all-trans retinoic acid (ATRA) in clinical trials of APL, and the clinical and basic research questions for future ...
David Eilender   +6 more
openaire   +3 more sources

Acute promyelocytic leukemia

American Journal of Hematology, 1979
AbstractAcute promyelocytic leukemia (APL) is characterized by proliferation of morphologically abnormal promyelocytes and a severe bleeding diathesis. The abnormal promyelocyte is characterized by abundant, large granules, many of which are spindle‐shaped. Electron microscopic appearance of the granules closely resembles that of Auer rods.
Jerome E. Groopman, Leonard Ellman
openaire   +2 more sources

Acute Lymphoid Leukemia

Pediatric Annals, 1983
During the past decade progress in the treatment of childhood acute lymphoblastic leukemia has slowed. A 50% to 60% cure barrier has frustrated a multitudinous array of therapeutic attempts to overcome this obstacle. With few exceptions, intensifications of induction, consolidation, or maintenance therapies have not overcome this obstacle.
openaire   +2 more sources

Home - About - Disclaimer - Privacy